NuGen Financial Statements From 2010 to 2026
| NGMDF Stock | USD 0.03 0.00 0.00% |
Check NuGen Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NuGen Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . NuGen financial statements analysis is a perfect complement when working with NuGen Medical Valuation or Volatility modules.
NuGen |
NuGen Medical Devices OTC Stock Return On Equity Analysis
NuGen Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NuGen Medical Return On Equity | -14.72 |
Most of NuGen Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuGen Medical Devices is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, NuGen Medical Devices has a Return On Equity of -14.7202. This is 38.59% lower than that of the Healthcare sector and 68.62% higher than that of the Medical Devices industry. The return on equity for all United States stocks is notably higher than that of the company.
NuGen Medical Devices Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuGen Medical's current stock value. Our valuation model uses many indicators to compare NuGen Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuGen Medical competition to find correlations between indicators driving NuGen Medical's intrinsic value. More Info.NuGen Medical Devices is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuGen Medical's earnings, one of the primary drivers of an investment's value.About NuGen Medical Financial Statements
NuGen Medical stakeholders use historical fundamental indicators, such as NuGen Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although NuGen Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in NuGen Medical's assets and liabilities are reflected in the revenues and expenses on NuGen Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in NuGen Medical Devices. Please read more on our technical analysis and fundamental analysis pages.
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventionalpediatric vaccines. Nugen Med operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in NuGen OTC Stock
NuGen Medical financial ratios help investors to determine whether NuGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGen with respect to the benefits of owning NuGen Medical security.